US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Women's Health Market Research Reports & Industry Analysis

Women’s health is a perspective of prevention and treatment that looks at health concerns unique to females. Even though slightly more than half of the US population is female, medical research historically has neglected the health needs of women, other than reproductive issues. Recently there have been major changes in government and private support of women’s health research -- in policies, regulations, and the organization of research efforts.
In a recent Institute of Medicine (IOM) report, the Washington DC-based institute found that women’s health research has contributed to significant progress over the past 20 years in lessening the burden of disease and reducing deaths from some conditions for women, while other conditions have seen only moderate change or even little or no change. Gaps remain, both in research areas and in the application of results to benefit women in general and across multiple population groups.

Viewing women’s health exclusively as a function of sex differences is too narrow, according to the IOM report. It frames women’s health and well-being as a function only of biological factors and how they differ in men and women, and ignores the role of gender, which is affected by broader social and community factors. The IOM finds that there has been inadequate attention paid to the social and environmental factors that, along with biologic risk factors, influence women’s health. Although progress has been made in identifying behavioral determinants of women’s health, such as smoking, diet, and physical activity, few studies have tested ways to modify these determinants in women or examined the effects of social and community factors in specific groups of women. To advance this area of research, the IOM recommends that the National Institutes of Health (NIH) support research on common determinants and risk factors that underlie multiple diseases.

Significant progress has been made in reducing mortality for women from breast cancer, cardiovascular disease and cervical cancer. This can be attributed in part to increased consumer demand and awareness, which has resulted in additional funding and research; improved diagnosis; screening and treatment; and, in the case of cervical cancer, a vaccine.

RSS Feeds

Women's Health Industry Research & Market Reports

< prev 1    3  4  5  6  7  8  9  10  
Breast Cancer Drug Pipeline Update 2015
6/17/2015 | published by: BioSeeker Group AB
... and metastatic setting, the overall survival remains below five years. There are today 573 companies plus partners developing 699 drugs targeting breast cancer in development. In addition, there are 8 suspended drugs and the accumulated ...  |  read more...
USD 6,750
Ovarian Cancer Drug Pipeline Update 2015
6/17/2015 | published by: BioSeeker Group AB
... an important secondary indication for existing and pipeline drugs. There are today 314 companies plus partners developing 418 drugs targeting ovarian cancer in development. In addition, there are 6 suspended drugs and the accumulated number ...  |  read more...
USD 6,750
Future Horizons and Growth Strategies in the Papillomavirus Testing Market 2015: Supplier Shares and Country Forecasts
6/11/2015 | published by: VPGMarketResearch.com
... report provides the 5-year test volume and sales forecasts by country for the following market segments: - Hospitals - Commercial/Private Labs - Physician Offices - Public Health Labs In addition to test volume and sales ...  |  read more...
USD 4,350
Future Horizons and Growth Strategies in the Pap Smear/HPV Testing Market 2015: Country Forecasts
6/11/2015 | published by: VPGMarketResearch.com
... the disease. During the next five years, the worldwide cancer testing market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting ...  |  read more...
USD 5,450
Netherton Syndrome (Trichorrhexis Invaginata, Bamboo Hair)-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... Hair). The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Netherton Syndrome (Trichorrhexis Invaginata, Bamboo Hair) Report helps to identify emerging players with ...  |  read more...
USD 1,250
Post Menopausal Osteoporosis-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Post Menopausal Osteoporosis Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. ...  |  read more...
USD 1,250
2015 Strategies in the Chlamydia Diagnostic Testing Market
5/27/2015 | published by: VPGMarketResearch.com
... report provides the 5-year test volume and sales forecasts by country for the following market segments: - Hospitals - Commercial/Private Labs - Physician Offices - Public Health Labs For each country, in addition to test ...  |  read more...
USD 4,350
Uterine Cancer-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... related research activities, technology, collaborations, in-licensing and out-licensing deals. The Uterine Cancer Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Uterine Cancer- Pipeline ...  |  read more...
USD 1,250
Uterine Fibroids-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... related research activities, technology, collaborations, in-licensing and out-licensing deals. The Uterine Fibroids Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Uterine Fibroids- Pipeline ...  |  read more...
USD 1,250
Vaginitis -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... related research activities, technology, collaborations, in-licensing and out-licensing deals. The Vaginitis Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Vaginitis - Pipeline Insights, ...  |  read more...
USD 1,250
Bacterial Vaginosis-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... related research activities, technology, collaborations, in-licensing and out-licensing deals. The Bacterial Vaginosis Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Bacterial Vaginosis- Pipeline ...  |  read more...
USD 1,250
Hot Flashes-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... related research activities, technology, collaborations, in-licensing and out-licensing deals. The Hot Flashes Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Hot Flashes- Pipeline ...  |  read more...
USD 1,250
Dysmenorrhea-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... technology, collaborations, in-licensing and out-licensing deals. The Dysmenorrhea Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Dysmenorrhea- Pipeline Insights, 2015 Report covers the ...  |  read more...
USD 1,250
Epithelial Ovarian Cancer-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Epithelial Ovarian Cancer Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. ...  |  read more...
USD 1,250
Labor And Delivery-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Labor And Delivery Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. ...  |  read more...
USD 1,250
Post Menopausal Disorder-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Post Menopausal Disorder Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. ...  |  read more...
USD 1,250
Premenstrual Syndrome-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... related research activities, technology, collaborations, in-licensing and out-licensing deals. The Premenstrual Syndrome Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Premenstrual Syndrome- Pipeline ...  |  read more...
USD 1,250
Primary Dysmenorrhea-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... related research activities, technology, collaborations, in-licensing and out-licensing deals. The Primary Dysmenorrhea Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Primary Dysmenorrhea- Pipeline ...  |  read more...
USD 1,250
Vaginal Atrophy (Atrophic Vaginitis)-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Vaginal Atrophy (Atrophic Vaginitis) Report helps to identify emerging players with potentially strong product information and create effective counter-strategies ...  |  read more...
USD 1,250
Vaginal Infections-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... related research activities, technology, collaborations, in-licensing and out-licensing deals. The Vaginal Infections Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Vaginal Infections- Pipeline ...  |  read more...
USD 1,250
Vasomotor Symptoms of Menopause-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Vasomotor Symptoms of Menopause Report helps to identify emerging players with potentially strong product information and create effective counter-strategies ...  |  read more...
USD 1,250
Vulvar Cancer-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... related research activities, technology, collaborations, in-licensing and out-licensing deals. The Vulvar Cancer Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Vulvar Cancer- Pipeline ...  |  read more...
USD 1,250
Global In Vitro Fertilization (IVF) & Male and Female Fertility treatment market, Industry Overview, Size, Share, Trends, Opportunities, Global Demand, Insights, Analysis, Research, Report, Segmentation and Forecast 2014 - 2020
5/22/2015 | published by: Occams Business Research & Consultancy
... (IVF) & Male and Female Fertility treatment market, Industry Overview, Intra cytoplasmic sperm injection, IVF market, Materials & Chemicals, Medical Devices, Protein Purification, Gene Expression, DNA & RNA , Pharmaceuticals, Analytical Reagents Market and Technology, ...  |  read more...
USD 4,000
Post Menopausal Osteoporosis - Pipeline Review, H1 2015
4/29/2015 | published by: Global Markets Direct
... information on the therapeutic development for Post Menopausal Osteoporosis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest ...  |  read more...
USD 2,000
Premarin Tablet-API Insights, 2015
4/21/2015 | published by: DelveInsight
... United States Drug Master File (USDMF) and Europe DMF filed by worldwide countries related to the Premarin Tablet. The Report provides the India and China API Manufactures who are driving the current API Market. DelveInsight’s ...  |  read more...
USD 500
< prev 1    3  4  5  6  7  8  9  10